Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism
- PMID: 32835228
- PMCID: PMC7371821
- DOI: 10.1186/s40575-020-0081-4
Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism
Abstract
Background: Canine hypoadrenocorticism is an immune-mediated endocrinopathy that shares both clinical and pathophysiological similarities with Addison's disease in humans. Several dog breeds are overrepresented in the disease population, suggesting that a genetic component is involved, although this is likely to be polygenic. Previous research has implicated CTLA4 as a potential susceptibility gene. CTLA4 is an important regulator of T cell function and polymorphisms/mutations in CTLA4 have been associated with a number of autoimmune phenotypes in both humans and rodent models of autoimmunity. The aim of the current study was to undertake a case:control association study of CTLA4 promotor polymorphisms in three dog breeds, cocker spaniels, springer spaniels and West Highland white terriers (WHWT).
Results: Polymorphisms in the CTLA4 promoter were determined by PCR and sequence-based typing. There were significant associations with three promoter haplotypes in cocker spaniels (p = 0.003). A series of SNPs were also associated with hypoadrenocorticism in cocker spaniels and springer spaniels, including polymorphisms in predicted NFAT and SP1 transcription factor binding sites.
Conclusions: This study provides further evidence that CTLA4 promotor polymorphisms are associated with this complex genetic disease and supports an immune mediated aetiopathogenesis of canine hypoadrenocorticism.
Keywords: Addison’s; CTLA-4; Canine; Hypoadrenocorticism; Promoter.
© The Author(s). 2020.
Conflict of interest statement
Competing interestsLorna J Kennedy is Managing Editor on Canine Medicine and Genetics. However, she will not be involved in the decision-making of this paper. The other authors declare no competing interests.
Figures



References
-
- Scott-Moncrieff JC. Hypoadrenocorticism. In: Canine Feline Endocrinol: Elsevier; 2015. p. 485–520. 10.1016/B978-1-4557-4456-5.00012-2.
-
- Boag AM, Christie MR, McLaughlin KA, Syme HM, Graham PA, Catchpole B. Autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with Hypoadrenocorticism (Addison’s disease) PLoS One. 2015;10:e0143458. doi: 10.1371/journal.pone.0143458. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources